Latest filing published 29 May 2020 for Merit Medical Systems INC, €63k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Nolan E. Karras: trading record in brief
Nolan E. Karras discloses dealings in Merit Medical Systems Inc to SEC (Form 4). Between 28 February 2012 and 28 May 2020, the trades on record add up to 22 filings.
Market trades split into 4 purchases (€75k) and 9 sales (€1.5M). Taken together, the sales exceed the purchases by €1.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 9 option exercises. So far in 2020, the count stands at no purchases and 3 sales.
The median purchase comes to €19k.
Most recently, on 29 May 2020, the filings show an open-market sale worth €200k in Merit Medical Systems Inc. The clock since the last published purchase (1 March 2012) now reads 5,366 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nolan E. Karras
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$13.998.1% of flowCommon Stock, No Par ValueSEC:0001415889-20-001371:0
- 5,000 shares@ US$44.1225.7% of flowCommon Stock, No Par ValueSEC:0001415889-20-001371:1
- 5,000 shares@ US$13.998.1% of flowCommon Stock, No Par ValueSEC:0001415889-20-001371:2
- 5,000 shares@ US$43.8725.4% of flowCommon Stock, No Par ValueSEC:0001415889-20-001371:3
- 8,000 shares@ US$9.957.3% of flowCommon Stock, No Par ValueSEC:0001104659-20-028705:0
- 5,500 shares@ US$36.6918.6% of flowCommon Stock, No Par ValueSEC:0001104659-20-028705:1
- 8,000 shares@ US$9.955.2% of flowCommon Stock, No Par ValueSEC:0000856982-19-000117:0
- 4,000 shares@ US$36.469.5% of flowCommon Stock, No Par ValueSEC:0000856982-19-000117:1
- 4,000 shares@ US$60.9115.6% of flowCommon Stock, No Par ValueSEC:0000856982-19-000095:1
- 6,000 shares@ US$9.953.8% of flowCommon Stock, No Par ValueSEC:0000856982-19-000095:0
- 2,000 shares@ US$61.287.8% of flowCommon Stock, No Par ValueSEC:0000856982-18-000090:1
- 3,000 shares@ US$9.951.9% of flowCommon Stock, No Par ValueSEC:0000856982-18-000090:0
- 8,000 shares@ US$12.914.3% of flowCommon Stock, No Par ValueSEC:0001179110-17-009755:0
- 7,000 shares@ US$37.1510.9% of flowCommon Stock, No Par ValueSEC:0001179110-17-009755:1
- 6,122 shares@ US$12.913.4% of flowCommon Stock, No Par ValueSEC:0001179110-16-028699:0
- 6,122 shares@ US$23.446.1% of flowCommon Stock, No Par ValueSEC:0001179110-16-028699:1
- 5,878 shares@ US$12.913.2% of flowCommon Stock, No Par ValueSEC:0001179110-16-028333:0
- 5,878 shares@ US$23.355.8% of flowCommon Stock, No Par ValueSEC:0001179110-16-028333:1
- 2,000 shares@ US$12.56Common Stock, No Par ValueSEC:0001179110-12-003958:0Canonical exit: 28 May 2012 (T+90)
- 2,000 shares@ US$12.55Common Stock, No Par ValueSEC:0001179110-12-003958:1Canonical exit: 30 May 2012 (T+90)
20 of 20 declarations
